Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform


Out of Business LATEST DEAL TYPE

Developer of a proprietary technology platform designed to discover prophylactic and therapeutic vaccines. The company's platform develops effective vaccines that are delivered to the upper layers of skin rather than into muscle like conventional vaccines that can mediate a dramatically strong and effective immune response against viruses and bacteria, enabling users to stay healthy and build immunity.

Ownership Status
Out of Business
Financing Status
Formerly Angel backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 67 Broad Street
  • Boston, MA 02109
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore TremRx’s full profile, request a free trial.

TremRx Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Mar-2019 Completed Out of Business
1. Seed Round Completed Startup
To view this company’s complete deal history including valuation and funding, request access »